An observational study in Pneumoconiosis, sponsored by China-Japan Friendship Hospital. Recruiting at 1 site in China. Per ClinicalTrials.gov, last updated 2025-07-22.
Sponsored by China-Japan Friendship Hospital · Observational
The primary objective of this study is to characterize the demographic and clinical features of patients with occupational pneumoconiosis (hereinafter referred to as pneumoconiosis) in China. Secondary objectives include: 1) to describe the natural course of pneumoconiosis; 2) to evaluate the prognosis of pneumoconiosis patients; and 3) to assess complications and comorbidities in pneumoconiosis patients.
China-Japan Friendship Hospital is the lead sponsor of 173 studies on the registry; 109 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients were selected during physical examinations or during hospitalization from medical organization.
Exclusion Criteria:
This group is composed of patients with pneumoconiosis.
This group is composed of patients exposed to dust.
This group is composed of healthy control subjects.
Pulmonary function test
Pulmonary function tests (PFTs) are utilized to assess the severity of the patient's condition, monitor disease progression, guide therapeutic decision-making, and evaluate prognosis.
Time frame: 3 years
Number of patients
The researchers used inclusion/exclusion criteria for screening, and collected the demographic information, clinical symptoms and signs, laboratory tests, treatment, survival and other conditions of the patients who agreed to participate in the program and signed the informed consent, and collected biological specimens.
Time frame: 6 years
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Pneumoconiosis
China-Japan Friendship Hospital